Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The interplay between organizational culture and burnout among ICU professionals: A cross-sectional multicenter study.
Kok N, Hoedemaekers C, Fuchs M, Cornet AD, Ewalds E, Hom H, Meijer E, Meynaar I, van Mol M, van Mook W, van der Steen-Dieperink M, van Zanten A, van der Hoeven H, van Gurp J, Zegers M. Kok N, et al. Among authors: cornet ad. J Crit Care. 2024 Nov 27;85:154981. doi: 10.1016/j.jcrc.2024.154981. Online ahead of print. J Crit Care. 2024. PMID: 39608045
The INTOXICATE study: methodology and preliminary results of a prospective observational study.
Zwaag SM, van den Hengel-Koot IS, Baker S, Druwé P, Elhadi M, Dufol AF, Forsberg S, Halacli B, Jung C, Laubner Sakalauskienė G, Lindqvist E, Moreno R, Rabe C, Reiter N, Rezar R, Țincu R, Topeli A, Wood DM, de Lange DW, Hunault CC; INTOXICATE Study Investigators Group. Zwaag SM, et al. Crit Care. 2024 Sep 27;28(1):316. doi: 10.1186/s13054-024-05096-7. Crit Care. 2024. PMID: 39334221 Free PMC article.
Effect of high versus standard protein provision on functional recovery in people with critical illness (PRECISe): an investigator-initiated, double-blinded, multicentre, parallel-group, randomised controlled trial in Belgium and the Netherlands.
Bels JLM, Thiessen S, van Gassel RJJ, Beishuizen A, De Bie Dekker A, Fraipont V, Lamote S, Ledoux D, Scheeren C, De Waele E, van Zanten ARH, Bormans-Russell L, van Bussel BCT, Dictus MMJ, Fivez T, Harks I, van der Horst ICC, Jonckheer J, Marechal H, Massion PB, Meex I, Paulus MC, Rinket M, van Santen S, Tartaglia K, Deane AM, Demuydt F, Puthucheary Z, Vloet LCM, Weijs PJM, van Kuijk SMJ, van de Poll MCG, Mesotten D; PRECISe study team. Bels JLM, et al. Lancet. 2024 Aug 17;404(10453):659-669. doi: 10.1016/S0140-6736(24)01304-7. Lancet. 2024. PMID: 39153816 Clinical Trial.
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.
Mesinovic M, Wong XC, Rajahram GS, Citarella BW, Peariasamy KM, van Someren Greve F, Olliaro P, Merson L, Clifton L, Kartsonaki C; ISARIC Characterisation Group. Mesinovic M, et al. Sci Rep. 2024 Jul 16;14(1):16387. doi: 10.1038/s41598-024-63212-7. Sci Rep. 2024. PMID: 39013928 Free PMC article.
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.
Citarella BW, Kartsonaki C, Ibáñez-Prada ED, Gonçalves BP, Baruch J, Escher M, Pritchard MG, Wei J, Philippy F, Dagens A, Hall M, Lee J, Kutsogiannis DJ, Wils EJ, Fernandes MA, Tirupakuzhi Vijayaraghavan BK, Panda PK, Martin-Loeches I, Ohshimo S, Fatoni AZ, Horby P, Dunning J, Rello J, Merson L, Rojek A, Vaillant M, Olliaro P, Reyes LF; ISARIC Clinical Characterisation Group. Citarella BW, et al. Heliyon. 2024 May 4;10(10):e29591. doi: 10.1016/j.heliyon.2024.e29591. eCollection 2024 May 30. Heliyon. 2024. PMID: 38779000 Free PMC article.
Ghrelin for Neuroprotection in Post-Cardiac Arrest Coma: A Randomized Clinical Trial.
Nutma S, Beishuizen A, van den Bergh WM, Foudraine NA, le Feber J, Filius PMG, Cornet AD, van der Palen J, van Putten MJAM, Hofmeijer J; GRECO Investigators. Nutma S, et al. Among authors: cornet ad. JAMA Neurol. 2024 Jun 1;81(6):603-610. doi: 10.1001/jamaneurol.2024.1088. JAMA Neurol. 2024. PMID: 38709502 Clinical Trial.
98 results